Switch Language
Alt tag

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!

Subscribe

See Also

Peripheral Artery Disease: causes and consequences

Coronary Artery Disease: causes and consequences

Thrombosis Digest 2022

International Society on Thrombosis and Haemostasis (ISTH) Congress 2022 Newsletter

International Society on Thrombosis and Haemostasis (ISTH) Congress 2022 Newsletter

International Society on Thrombosis and Haemostasis (ISTH) Congress 2022 Newsletter

International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) 2022

International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) 2022

International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) 2022

Your older patients with atrial fibrillation: Are you missing the broader picture?

Your older patients with atrial fibrillation: Are you missing the broader picture?

Your older patients with atrial fibrillation: Are you missing the broader picture?

EHRA 2022 Congress Highlights

EHRA 2022 Congress Highlights

EHRA 2022 Congress Highlights

Extended treatment for recurrent VTE: Protecting your patients for as long as they need

Extended treatment for recurrent VTE: Protecting your patients for as long as they need

Extended treatment for recurrent VTE: Protecting your patients for as long as they need

The use of NOACs in the extended management of cancer‑associated thrombosis

The use of NOACs in the extended management of cancer‑associated thrombosis

The use of NOACs in the extended management of cancer‑associated thrombosis

Protecting elderly patients with atrial fibrillation

Protecting elderly patients with atrial fibrillation

Protecting elderly patients with atrial fibrillation

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!